Croissance du BNPA(1) des activités de 8,8% à TCC au troisième trimestre 2020

by NASDAQ Market News October 29, 2020

NASDAQ Market News
Click here to email author

AB Science announces a financing of 4.5 million euros through the issuance of bonds convertible into new ordinary shares

Sanofi to evaluate the safety and efficacy of novel investigational candidate THOR-707 and KEYTRUDA® (pembrolizumab) in pursuit of establishing a new treatment option in oncology

Ads